Collaboration aims to enhance logistics solutions for advanced therapies and radiopharmaceuticals, ensuring timely delivery and expanding patient access
St. Louis, Missouri — September 18, 2024 — Orchestra Life Sciences, a leading technical consultancy supporting clients in cell and gene therapy and radiopharmaceuticals, today announced a strategic partnership with Life Couriers, a global leader in specialized healthcare logistics, to enhance supply chain capabilities for the distribution of life-saving cancer treatments. The partnership will focus on expanding access to advanced cell and gene therapies (CGTs) and radiopharmaceuticals by optimizing the logistics process to ensure timely and efficient delivery to patients in need.
This collaboration marks a significant step toward addressing one of the most critical challenges in the advanced therapy industry: the ability to deliver cutting-edge therapies to patients efficiently, especially when time to treatment is crucial. Through this partnership, Orchestra Life Sciences will bring Life Couriers’ expertise to its clients to streamline key logistics between therapy developers and patients, minimizing delays and ensuring that life-saving treatments reach patients when they need them most.
“The supply chain is a critical pillar in ensuring the success of advanced therapies, especially in the cell, gene, and radiopharmaceutical space. Time to treatment is vital for these patients, and any delay can be life-altering,” said Emilie Pelletier, CEO of Orchestra Life Sciences. “Our partnership with Life Couriers strengthens our ability to deliver life-saving therapies efficiently and reliably. By expanding access to these treatments and meeting patients where they are, we can make a significant impact on their outcomes and provide hope to those facing serious conditions.”
The partnership will leverage Life Couriers’ global logistics network and state-of-the-art Control Towers, which provide real-time monitoring and oversight of supply chain operations 24/7/365. This level of precision and reliability will help both companies ensure that advanced therapies, including personalized CGTs and radiopharmaceuticals with short half-lives, reach patients in perfect condition and on time.
“We are excited to partner with Orchestra Life Sciences to make a meaningful difference in the lives of patients,” said Matt Silverberg, CCO of Life Couriers. “Our mission is to ensure that every step in the delivery process works seamlessly to connect patients with the life-saving treatments they depend on. This partnership allows us to expand market access to these critical products and help improve patient outcomes globally.”
This partnership not only improves the overall efficiency of supply chain management for commercial products but also broadens access to support critical clinical trial programs, particularly for autologous cell therapies that could potentially improve regulatory outcomes and support expanded access programs.
About Orchestra Life Sciences
Orchestra Life Sciences is a technical consultancy supporting clients in cell and gene therapy and radiopharmaceuticals. As the premier consultancy in advanced therapies, Orchestra Life Sciences assists clients with all facets of business strategy, production, supply chain, logistics, capital projects and operations.
With a focus on innovation and patient-centered care, Orchestra Life Sciences partners with leading organizations to bring novel treatments to market, improve patient outcomes, and expand access to life-saving therapies globally.
About Life Couriers:
Life Couriers is an international group of specialized logistics service operators focused on life science and healthcare logistics. The group offers the broadest service portfolio on the market through six business segments: Stem Cell Onboard, Radiopharma, Life Science, Direct-to-Patient, Pharma Freight and Emergency Logistics. With locations in the US, UK, Germany, France, Belgium, Czech Republic, Italy, Sweden, Romania, Austria, Denmark, Mexico, Switzerland & Honduras, Life Couriers has a worldwide reach.
Life Couriers is operated by SLS Group GmbH, headquartered in Munich, Germany, and is led by Stefan Glebke as CEO. The group currently employs over 750 people worldwide. In 2023, Life Couriers generated a turnover of €230m. More information at www.lifecouriers.com
For media inquiries:
Orchestra Life Sciences
Emilie Pelletier
Chief Executive Officer
info@orchestralifesciences.com
www.orchestralifesciences.com
Life Couriers
Tom Wells
Marketing Manager
marketing@lifecouriers.com
www.lifecouriers.com